Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is increasingly used for rapid bacterial identification. Studies of Burkholderia pseudomallei identification have involved small isolate numbers drawn from a restricted geographic region. There is a need to expand the reference database and evaluate B. pseudomallei from a wider geographic distribution that more fully captures the extensive genetic diversity of this species. Here, we describe the evaluation of over 650 isolates. Main spectral profiles (MSP) for 26 isolates of B. pseudomallei (N = 5) and other Burkholderia species (N = 21) were added to the Biotyper database. MALDI-TOF MS was then performed on 581 B. pseudomallei, 19 B. mallei, 6 B. thailandensis and 23 isolates representing a range of other bacterial species. B. pseudomallei originated from northeast and east Thailand (N = 524), Laos (N = 12), Cambodia (N = 14), Hong Kong (N = 4) and Australia (N = 27). All 581 B. pseudomallei were correctly identified, with 100% sensitivity and specificity. Accurate identification required a minimum inoculum of 5 x 107 CFU/ml, and identification could be performed on spiked blood cultures after 24 hours of incubation. Comparison between a dendrogram constructed from MALDI-TOF MS main spectrum profiles and a phylogenetic tree based on recA gene sequencing demonstrated that MALDI-TOF MS distinguished between B. pseudomallei and B. mallei, while the recA tree did not. MALDI-TOF MS is an accurate method for the identification of B. pseudomallei, and discriminates between this and other related Burkholderia species.
Citation: Suttisunhakul V, Pumpuang A, Ekchariyawat P, Wuthiekanun V, Elrod MG, Turner P, et al. (2017) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of Burkholderia pseudomallei from Asia and Australia and differentiation between Burkholderia species. PLoS ONE 12(4): e0175294. https://doi.org/10.1371/journal.pone.0175294
Editor: Adriana Calderaro, Universita degli Studi di Parma, ITALY
Received: August 26, 2016; Accepted: March 23, 2017; Published: April 6, 2017
Copyright: © 2017 Suttisunhakul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This study was supported by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z to NC) (http://www.wellcome.ac.uk) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number U01AI115520 to NC (https://www.nih.gov). VS was supported by a Ph.D. scholarship from Faculty of Tropical Medicine Mahidol University (www.tm.mahidol.ac.th). The funder had no role in study design and interpretation, or the decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The genus Burkholderia is composed of Gram-negative species that are predominantly non-pathogenic environmental saprophytes. A clinically important exception is Burkholderia pseudomallei, which causes an estimated 165,000 cases of melioidosis per year worldwide, of which 89,000 are predicted to be fatal . A high proportion of reported cases occur in northeast Thailand, where melioidosis is the second most common cause of community-acquired bacteremia and the third most common cause of death from infectious diseases . B. pseudomallei receives additional attention because of its biothreat potential , and because of infection in travelers returning from endemic regions [4, 5]. In Thailand, B. pseudomallei is widely distributed in soil and environmental water [6–8] and may be found together with the closely related B. thailandensis, which is very rarely associated with human disease .
Making an accurate diagnosis of melioidosis is key to patient outcome since empiric antimicrobial therapy for sepsis does not include the first-line drugs recommended for melioidosis (ceftazidime or a carbapenem). Diagnosis relies on bacterial isolation and identification since clinical manifestations lack specificity. B. pseudomallei may be isolated from a range of clinical specimen types, but half of melioidosis cases have positive blood cultures. Direct identification of B. pseudomallei in positive blood cultures can reduce the time to diagnostic confirmation by 24 hours. This can be achieved using a rapid immunofluorescent assay (IFA), in which the most common antibody described is a monoclonal that recognizes B. pseudomallei capsular polysaccharide (CPS) . This reagent is also used in a latex agglutination assay that can identify B. pseudomallei directly in blood cultures, other sample types, and colonies picked from culture media . A monoclonal antibody against CPS has also been incorporated into a lateral flow assay , which can detect B. pseudomallei directly in a range of clinical samples and cultures.
The recent recognition of a B. thailandensis variant that expresses B. pseudomallei-like capsular polysaccharide (Bp-like CPS)  has important implications for the accuracy of B. pseudomallei identification assays based on antibody detection of CPS, since this gives a false positive result. The potential relevance of this has increased with the recent finding that B. thailandensis expressing Bp-like CPS is widely distributed in the environment in Thailand (V. Hantrakul, personal communication). Occasional cross-reacting isolates of B. cepacia have also been observed (D. Dance, personal communication). Methods that distinguish between B. pseudomallei and other Burkholderia species such as B. thailandensis include arabinose assimilation, more extended biochemical testing such as that incorporated in the commercial API 20NE biochemical kit (bioMérieux), real-time PCR, and sequencing [14–20]. Automated identification systems are available in many laboratories, although these may misidentify B. pseudomallei as B. cepacia [21–24].
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been increasingly introduced into diagnostic laboratories for rapid bacterial identification. The first published study of its application to Burkholderia spp. evaluated 10 B. pseudomallei and 17 B. mallei isolates and generated reference spectra data . Several case reports have since reported its use to diagnose melioidosis, including infection in returning travelers [5, 26–29]. It has also been reported to differentiate between B. pseudomallei wild-type and single gene mutants , to delineate clustering in a collection of 11 B. pseudomallei from northeast Thailand , and to determine ceftazidime resistance simultaneously with B. pseudomallei identification . An inter-laboratory trial for the identification of highly pathogenic bacteria using MALDI-TOF MS included one isolate each of B. pseudomallei and B. mallei and concluded that a compilation of complete and comprehensive databases with spectra from a broad strain collection was of paramount importance for accurate microbial identification . The largest evaluation of B. pseudomallei to date was undertaken using 66 B. pseudomallei. Nearly all of these (62/66 isolates) were initially misidentified as B. thailandensis using an existing database (DB5627), but an enhanced database subsequently identified all correctly . A limitation of this study was that most of the isolates (63/66) were from a single country (Taiwan), the remaining 3 originating from Beijing, China.
At the time that this study was performed, representation of the 30 Burkholderia species in the biotyper database was limited and did not include B. pseudomallei, B. ubonensis, B. oklahomensis, B. humptydooensis or B. mallei. This indicates a need to expand the reference database and potentially increase the sensitivity and specificity of the assay. Furthermore, the need remains to undertake an evaluation of MALDI-TOF MS to identify B. pseudomallei drawn from a wider geographic distribution, which is important because of the genetic distinctiveness of isolates from Asia compared with Australasia and the highly plastic and variable genome, both of which could impact on the performance of MALDI-TOF MS. Previous studies have also lacked the inclusion of B. thailandensis expressing Bp-like CPS. The aim of this study was to expand the MALDI-TOF MS database with Burkholderia spp. and then evaluate this technology using a large collection of B. pseudomallei together with other Burkholderia spp. including B. thailandensis expressing Bp-like CPS. We added value to our findings by testing its performance using blood cultures spiked with B. pseudomallei, and evaluating the similarity between B. pseudomallei clusters arising from MALDI-TOF MS data compared with phylogenetic characterization based on recA sequence data.
Materials and methods
B. pseudomallei and other Burkholderia species used in this study are detailed in Table 1. In brief, these included 5 laboratory B. pseudomallei strains, 581 B. pseudomallei isolated from the environment, humans or animals, 46 isolates belonging to eight other Burkholderia species, and 23 isolates representing a range of other bacterial pathogens. B. pseudomallei were cultured from humans (N = 550) or other animals (N = 14) with melioidosis, or from the environment (N = 17), and originated from northeast and east Thailand (N = 524), Laos (N = 12), Cambodia (N = 14), Hong Kong (N = 4) and Australia (N = 27). A single isolate was used from each patient, animal or environmental source. The other bacterial species were: Acinetobacter baumannii, Enterobacter aerogenes NCTC 10006, E. cloacae, Enterococcus faecalis ATCC 29212, Escherichia coli, Haemophilus influenzae NCTC 11931, Hafnia alvei, Klebsiella oxytoca, K. pneumoniae ATCC 700603, Morganella morganii, Neisseria gonorrhoeae, Proteus mirabilis, Pseudomonas aeruginosa, P. putida, P. stutzeri, Salmonella enterica serovar Paratyphi A, S. enterica serovar Paratyphi B NCTC 3176, S. enterica serovar Typhi NCTC 8385, Seratia marcescens, Staphylococcus aureus ATCC 25923, Stenotrophomonas maltophilia, Streptococcus pneumoniae ATCC 49619 and S. pyogenes. The original identification of B. pseudomallei was performed by the submitting laboratories using a range of different methods that reflected variation in clinical and research practice and the lack of a single gold standard method. In Asia, the predominant method used was a combination of colony morphology, antibiotic susceptibility pattern, arabinose assimilation and latex agglutination . Elsewhere, colony appearance followed by API20NE (bioMérieux) was commonly used. Other Burkholderia species were identified using one or more of biochemical methods, including 16S rRNA sequence, recA sequence and DNA-DNA hybridization [14–20]. Additional, non-Burkholderia species were identified using standard laboratory methodology supplied by the Department of Medical Science, Ministry of Public Health, Thailand. All isolates were shipped in accordance with international guidelines to an accredited BSL-3 laboratory in Bangkok where the evaluation was conducted. Unless otherwise specified, bacteria were cultured on Columbia agar at 37°C in air for 24 h. All isolates were stored in trypticase soy broth (TSB) with 15% glycerol at -80°C.
Latex agglutination test and multilocus sequence typing
Latex agglutination reagent based on the 4B11 monoclonal antibody to capsular polysaccharide of B. pseudomallei was prepared and the assay performed as previously described [11, 35]. Multilocus sequence type (ST) was known for 21 B. pseudomallei, 21 B. mallei and 10 B. thailandensis isolates, which have been reported previously [13, 36, 37].
MALDI-TOF MS analysis
Protein was extracted from bacteria using the formic acid extraction method as previously described [38, 39], with several modifications. In brief, a loopful of bacteria was harvested from an agar plate and suspended in 300 μl ultra-pure distilled water (UDW), to which 900 μl absolute ethanol (Merck, Darmstadt, Germany) was added. The suspension was centrifuged at 16,200 g for 2 min and the pellet left to dry at room temperature. Twenty-five microliters of 70% formic acid (V/V) (Sigma-Aldrich, Fluka, MO, USA) was added and mixed thoroughly, followed by an equal volume of acetonitrile (Merck, Darmstadt, Germany). The mixture was centrifuged at 16,200 g for 2 min, and then 1 μl of supernatant was spotted onto a MSP-384 polished steel target plate (Bruker Daltonics, Germany). After drying in air, all spots were overlaid with 1 μl of matrix, α-cyano-4-hydroxycinnamic acid (HCCA) (Bruker Daltonics, Germany) dissolved in a solution of 50% acetonitrile, 2.5% trifluoroacetic acid and 47.5% water (Sigma-Aldrich, Fluka, MO, USA). Each spot was measured in 200 shot steps for a total of 1200 laser shots using an MALDI-TOF Mass Spectrometer Autoflex speed (Bruker Daltonics, Germany) and FlexControl software (version 3.4.135, Bruker Daltonics, Germany). Spectra were obtained in the linear positive mode with an accelerating voltage of 19.5 kV and analyzed within a mass range of 2,000–20,000 Da. Before measurement, the instrument was calibrated using the Bacterial Test Standard (BTS) following the manufacturer’s instructions (Bruker Daltonics, Germany). E. coli DH5-Alpha was used as a positive control and matrix solution was used as a negative control. Identification was achieved using the MALDI-Biotyper software (version 3.1, Bruker Daltonics, Germany). These experiments were performed in duplicate and the scores were averaged. Interpretation was performed according to the manufacturer’s recommendation; score of ≥ 2.3, reliable species level identification; 2.0–2.29, probable species level identification; 1.7–1.9, probable genus level identification; ≤ 1.7, unreliable identification . In a pilot study, at least 4 colonies (size ~ 1 mm) were required for B. pseudomallei to be identified with a score of ≥ 2.3.
MALDI-TOF MS reference database
The Bruker Daltonics database (version 22.214.171.124) was expanded by adding main spectrum profiles (MSP) for 26 isolates after adjusting the baseline and smoothness using Flexanalysis software (version 3.4, Bruker Daltonics, Germany). Twenty spots of a single protein extract from each isolate were used to construct the MSP using the MALDI-Biotyper software (version 3.1). The isolates used were as follows: B. pseudomallei (K96243, H2660a, H2708a, 1106a and 1026b), B. cepacia (LNT40, 10223, 2.1B, 39628, MI1035, NCTC 10744, SBCAU015 and U668), B. humptydooensis (MSMB43), B. mallei (NCTC 10247 and Mongolia 1), B. multivorans (LMG16660), B. oklahomensis (c6786, c7532 and c7533), B. thailandensis (E175, E264, E421 and E426), B. ubonensis (DMST866) and B. vietnamiensis (LMG6999). The five B. pseudomallei isolates were selected as these have been used extensively as reference isolates, and whole genome sequence and sequence type (ST) data are available (K96243, ST10; H2660a, ST 54; H2708a, ST60; 1106a, ST70; and 1026b, ST102). These STs also represent the major B. pseudomallei STs in Thailand . B. mallei evolved from a single lineage of B. pseudomallei and the two isolates selected here (NCTC 10247 and Mongolia 1) were used previously as reference isolates is a study that described the discrimination between B. mallei and B. pseudomallei . B. ubonensis, B. oklahomensis, B. humptydooensis and B. vietnamiensis are rarely described and all isolates belonging to these species in our collection were used. B. cepacia, B. multivorans and B. thailandensis were added since they may be misidentified as B. pseudomallei by some identification systems.
Identification of specific peaks for the discrimination of Burkholderia species
The Clinprotools software (version 3, Bruker Daltonics, Germany) was used to identify peaks that discriminated between Burkholderia species. This was performed using 20 replicates of a single protein preparation from each of nine Burkholderia species and B. thailandensis with Bp-like CPS: B. multivorans LMG16660, B. ubonensis DMST866, B. vietnamiensis LMG6999, B. cepacia NCTC 10744, B. oklahomensis c7533, B. thailandensis E264, B. thailandensis (Bp-like CPS) E555, B. humptydooensis MSMB43, B. pseudomallei K96243, and B. mallei NCTC 3708. Three independent experiments (20 replicates for each experiment) were performed and the results of each experiment checked for consistency of the discriminating peaks.
The statistical algorithms incorporated in the Clinprotools software (Quick Classifier (QC)/ Different Average, Supervised Neural Network (SNN) and the Genetic Algorithm (GA)) were used to analyze protein peaks between 2,000 and 20,000 Da. Potentially discriminatory peaks were identified based on high reliable prediction and separation based on cross validation values (>90%), as described previously . Three statistical tests (Anderson-Darling (AD), t-test/ANOVA (TTA), and Wilcoxon/Kruskal-Wallis (W/KW) are incorporated into Clinprotools and were used to analyse intensity data. All discriminatory peaks that exhibited P-values of <0.01 by any of these statistical test were further evaluated by eye  and validated with the peaks of other isolates from the same species. Peaks that were unique to specific species or statistically different in intensity and showed consistent results from three independent experiments were considered as the discriminatory peaks. All Burkholderia isolates used the for identification of discriminating peaks were used for the construction of a dendrogram.
MALDI-TOF MS dendrogram
To construct the dendrogram, Flexanalysis software (version 3.4) was used to adjust the baseline and smoothness of the spectra. Twenty spots of a single protein extract for each isolate were used to construct the main spectrum profiles (MSP) using the MALDI-Biotyper software (version 3.1). The following parameters were used: the Biotyper MSP creation standard method was used, with a maximum mass error of each single spectrum of 2000, desired mass error for the MSP of 200, desired peak frequency minimum of 25%, and maximum desired peak number for the MSP of 70. The isolates used were: 21 B. pseudomallei (NR9921, 1710a, 1106a, 576a, 1026b, K96243, SBPTHE0359, H2659A, SBPTHE0024, H2660a, SBPTHE0411, H2613a, SBPTHE0031, H2820a, SBPTHE0383, H2708a, H1248a, SBPTHE0358, H2677a, H2689b, H2644a), 21 B. mallei (EY100, NCTC 10245, T1, T2, T3, EY2233, EY2235, EY2236, EY2237, EY2238, EY2239, NCTC 10229, NCTC 10248, NCTC 3708, NCTC 10230, NCTC 10260, NCTC 3709, NCTC 10247, Mongolia1, Mongolia 2, ATCC 23344), 10 B. thailandensis (E175, E264, E421, E426, E555, SBXPL007a, SBXCC006a, SBXCC001, SBXCB001, SBXPR001), 1 B. humptydooensis MSMB43, 3 B. oklahomensis (c6786, c7532, c7533), 8 B. cepacia (NCTC 10744, MI1035, LNT40, 2.1B, U668, 39628, 10223, SBCAU015), 1 B. vietnamiensis LMG6999, 1 B. ubonensis DMST866 and 1 B. multivorans LMG16660. The basis for the choice of B. pseudomallei isolates was the inclusion of commonly used reference isolates (K96243, H2660a, H2708a, 1106a and 1026b) and a further 16 isolates each assigned to a different ST (ST696, ST76, ST77, ST80, ST345, ST40, ST126, ST177, ST70, ST501, ST102, ST10, ST54 and ST60 (Fig 1). B. thailandensis and B. thailandensis with BP-like CPS capsule were randomly selected from our freezer archive. We included all of the B. mallei (N = 21), B. humptydooensis MSMB43 (N = 1), B. oklahomensis (N = 3), B. cepacia (N = 8), B. vietnamiensis (N = 1), B. ubonensis (N = 1) and B. multivorans (N = 1) in our collection. Cluster analysis was performed based on comparison of MSP using the following setting parameters: the distance measure was set to Spearman, the linkage was set to single, and score threshold value for a single organism was set at 1000.
Distance is displayed in relative units. Annotated with MLST sequence type (ST) where known; each color represents a ST. The latex agglutination test was based on a monoclonal that recognizes B. pseudomallei capsular polysaccharide.
Determination of minimum bacterial input for accuracy of MALDI-TOF
The minimum number of bacteria in suspension and minimum number of colonies required to achieve an accurate MALDI-TOF result were determined. To quantify the number of bacteria, the experiment was performed using bacterial suspension. B. pseudomallei K96243 was harvested from an overnight culture of Columbia agar, suspended in sterile saline, adjusted to approximately 1 x 107 CFU/ml and then serially diluted from 1 x 107 CFU/ml to 10 CFU/ml. Bacterial cells in 1ml of each dilution were harvested by centrifugation at 16,200 g for 2 min. Protein was extracted from each pellet prior to MALDI-TOF analysis as above. The bacterial count was confirmed using Columbia agar spread plates in triplicate and colony counts after overnight incubation at 37°C. To determine the minimum number of colonies required for MALDI-TOF, between 1 and 10 colonies (size ~1 mm) of B. pseudomallei K96243 were harvested from Columbia agar plates using a loop, suspended in UDW and the protein extracted from each. Extracts were analyzed in triplicate in both assays. Spectra with maximal absolute peak intensities ranging from 103 to 104 arbitrary units were considered for evaluation [42, 43].
Effect of culture media
The effect of culture media was examined for five B. pseudomallei isolates (K96243, NR9921, 1106a, 1026b and 576a). Bacteria were streaked onto Ashdown agar, blood agar, Columbia agar, chocolate agar, Luria-Bertani (LB) agar, MacConkey agar, Mueller-Hinton agar, trypticase soy agar and incubated at 37°C in air for 24 hours and harvested using a 1 μl loop (≥ 10 colonies, size ~1 mm). Bacteria were suspended in 300 μl UDW and the protein extracted and analyzed in triplicate using MALDI-TOF MS.
MALDI-TOF MS identification of B. pseudomallei in spiked blood culture
Three BACTEC Plus Aerobic/F bottles were each inoculated with 10 ml of whole blood drawn from a single healthy volunteer. An overnight culture of B. pseudomallei K96243 was adjusted to approximately 1 x 108 CFU/ml, serially diluted to a concentration of 100 CFU/ml, and 100 μl (10 CFU) inoculated into each bottle. The inoculum was confirmed using colony counts on agar plates. Bottles were incubated at 37°C with 200 rpm shaking. At 12, 16, 20 and 24 h after incubation, one ml from each bottle was withdrawn for protein extraction using ammonium 0.826% NH4Cl (W/V) as a lysis buffer, as described previously [44, 45] with modifications. Briefly, an equal volume of 0.826% NH4Cl was added to 1 ml of blood culture fluid, mixed and centrifuged at 16,200 g for 2 min. The pellet was lysed twice as above before washing twice with 1 ml ultrapure distilled water and centrifuged as before. The supernatant was discarded and the pellet used for protein extraction.
recA sequencing and phylogenetic analysis was performed as previously described . The isolates tested were B. pseudomallei (N = 6), B. mallei (N = 7), B. thailandensis (N = 2), B. thailandensis variant strains with Bp-like CPS (N = 1), B. ubonensis (N = 1), B. oklahomensis (N = 1), B. vietnamiensis (N = 1), B. cepacia (N = 5), B. humptydooensis (N = 1) and B. multivorans (N = 1). Genomic DNA was extracted and PCR amplification performed using BUR3, BUR4 and BUR5 primers as previously described . Products were visualized using agarose-gel electrophoresis and purified using ExoSAP-IT PCR Product Cleanup (Affymetrix UK Ltd., UK). Purified PCR products were sequenced by Macrogen Inc. (Korea). Nucleotide sequence of B. thailandensis E555 was obtained from the NCBI database (accession no. AECN01000010.1). All sequences were aligned and trimmed to a 348 bp region using Clustal W using MEGA software version 7 . A maximum likelihood tree was constructed using the Nearest-Neighbor-Interchange (NNI) and Tamura-Nei model  using MEGA software version 7.0.14 .
The study was approved by Ethics Committee of the Faculty of Tropical Medicine, Mahidol University (approval number MUTM 2016-034-01). The principal investigator's blood was used and verbal consent was obtained to participate in this study. The Ethics Committee of the Faculty of Tropical Medicine, Mahidol University approved the procedure.
Evaluation of MALDI-TOF MS for the identification of B. pseudomallei
Twenty replicates of B. pseudomallei K96243 were tested using MALDI-TOF MS and the Bruker Daltonics database version 126.96.36.199. These were all identified as B. thailandensis, with a median score below that for reliable species identification (median 1.96, range, 1.83–2.04). We noted that the Biotyper database did not contain B. pseudomallei, B. mallei, B. ubonensis, B. oklahomensis or B. humptydooensis, although did contain representation for 30 Burkholderia species (B. ambifaria (N = 2), B. andropogonis (N = 1), B. anthina (N = 2), B. caledonica (N = 1), B. caribensis (N = 1), B. cenocepacia (N = 2), B. cepacia (N = 9), B. diffusa (N = 1), B. dolosa (N = 1), B. fungorum (N = 1), B. gladioli (N = 5), B. glathei (N = 1), B. glumae (N = 1), B. lata (N = 1), B. latens (N = 1), B. metallica (N = 1), B. multivorans (N = 5), B. phenazinium (N = 1), B. phymatum (N = 1), B. plantarii (N = 1), B. pyrrocinia (N = 2), B. sacchari (N = 1), B. seminalis (N = 2), B. stabilis (N = 2), B. terricola (N = 1), B. tropica (N = 1), B. tuberum (N = 1), B. thailandensis (N = 1), B. vietnamiensis (N = 1) and B. xenovorans (N = 1)). We extended the database by adding reference profiles for B. pseudomallei (N = 5), B. mallei (N = 2), B. ubonensis (N = 1) B. oklahomensis (N = 3) and B. humptydooensis (N = 1), together with further examples of B. cepacia (N = 8), B. thailandensis (N = 4), B. multivorans (N = 1), and B. vietnamiensis (N = 1). We then tested the accuracy of MALDI-TOF MS for the identification of geographically and genetically diverse B. pseudomallei isolates. A large collection of 564 clinical and 17 environmental isolates from different locations in Thailand, and from Laos, Cambodia, Hong Kong and Australia was tested. MALDI-TOF identified all 581 B. pseudomallei isolates correctly (100% sensitivity), with a median score for all isolates of 2.49 (range 2.30–2.68, IQR, 2.43–2.54) and no misidentification at the species level (Table 2). B. pseudomallei isolates showed some variability in similarity scores against the 5 B. pseudomallei added here to the reference profiles. Despite this, the highest score was to B. pseudomallei for all 581 B. pseudomallei tested, with the second and third highest score being B. mallei (median score 2.21, range 1.68–2.46, IQR 2.14–2.29) and B. thailandensis (median score 2.01, range 1.62–2.22, IQR 1.95–2.06). The specificity of MALDI-TOF MS was evaluated by testing 25 isolates including B. mallei (N = 19), B. thailandensis (N = 6), and 23 isolates belonging to 21 species in other Genera (see Methods). These bacterial species were correctly identified, indicating 100% specificity.
Effect of culture media on MALDI-TOF MS identification
We evaluated whether the culture medium used to grow bacteria prior to MALDI-TOF MS affected the accuracy of identification. Five B. pseudomallei strains (NR9921, 1106a, 576a, K96243, 1026b) were grown overnight on eight different solid media. All isolate/media combinations were identified as B. pseudomallei, with an identification score of at least 2.45. The median scores (range) of five isolates were as follows: Ashdown agar, 2.59 (2.48–2.68); blood agar, 2.66 (2.49–2.75); Columbia agar, 2.65 (2.59–2.69); chocolate agar, 2.64 (2.48–2.67); Luria-Bertani (LB) agar, 2.65 (2.47–2.70); MacConkey agar, 2.59 (2.47–2.62); Mueller-Hinton agar, 2.63 (2.45–2.65); and trypticase soy agar 2.62 (2.49–2.67).
Identification of B. pseudomallei in spiked blood culture
Since the speed of identification of B. pseudomallei from blood culture is crucial for patient management, we tested whether MALDI-TOF MS would give an accurate identification of B. pseudomallei K96243 in spiked blood culture fluid. For this we used three 30 ml BACTEC Plus Aerobic/F blood culture bottles each containing 10ml of blood from a healthy volunteer, spiked with 10 CFU, and tested after 8, 10, 12 and 24 h of incubation at 37°C with shaking. Testing at 8, 10, 12 h showed unidentified or misidentified results, but accurate identification for B. pseudomallei was obtained at the 24 h time point (median identification score 2.25 (range 2.17–2.36)). Colony counting demonstrated that the bacterial concentration in the blood culture bottle fluid at 24 h was 2.1 x 109 CFU/ml.
Latex agglutination test
The latex agglutination test is used to rapidly identify B. pseudomallei colonies in our laboratory and elsewhere, and so we performed a comparative assessment of this versus MALDI-TOF MS. The isolates used were 21 B. pseudomallei, 21 B. mallei, 10 B. thailandensis, 3 B. oklahomensis, 8 B. cepacia, 1 B. vietnamiensis, 1 B. ubonensis and 1 B. multivorans. All B. pseudomallei were positive by latex agglutination (Fig 1), as well as all B. thailandensis variants expressing Bp-like CPS, some strains of B. mallei (14/21, 66.7%), and three strains of B. cepacia (LNT40, 39628 and 10223) which had previously given false-positive results (D. Dance, personal communication).
Identification of discriminatory peaks
Twenty discriminatory peaks were identified from MSP spectra of representative isolates from 9 Burkholderia species and B. thailandensis with Bp-like CPS with cross validation results ranging between 98% and 100% (Fig 2 and S1 Table). Three peaks (around 2,600 Da, 4,414 Da and 5,200 Da) were observed for all nine Burkholderia species. Peaks that were unique to specific species were also observed, for example 2,908 Da for B. ubonensis, 3,932 Da for B. vietnamiensis, and 5,835 Da for B. thailandensis with Bp-like CPS. The only difference between B. thailandensis and B. thailandensis with Bp-like CPS was a peak of 5,835 Da. Compared to other Burkholderia species, peaks with highest intensity that were statistically different (P < 0.001) and useful to differentiate species were 2,049 Da for B. humptydooensis, 5,797 for B. pseudomallei, 7,558 Da for B. mallei and 7,859 Da for B. vietnamiensis. We checked these peaks with other isolates [B. pseudomallei (N = 21), B. mallei (N = 21), B. thailandensis (N = 4), B. thailandensis with Bp-like CPS (N = 6), B. oklahomensis (N = 3), B. cepacia (N = 8)] and found them to be reproducible in other isolates of the same species.
Phylogeny based on MALDI-TOF MS protein profiles and recA
A phylogenetic tree based on the MSP of 67 Burkholderia isolates divided nine species into two major branches (Fig 1). The first contained B. multivorans, B. vietnamiensis, B. ubonensis and B. cepacia, and the second contained B. thailandensis, B. oklahomensis, B. humptydooensis, B. mallei and B. pseudomallei. B. pseudomallei and B. mallei resided in distinct lineages but were more related to each other than to B. thailandensis. Sequence types had been defined previously for the B. mallei and B. pseudomallei isolates [36, 37] and are shown in Fig 1. B. mallei isolates belonged to a single ST (ST40), while B. pseudomallei belonged to 8 different STs.
A phylogenetic tree based on recA sequence was compared with the MALDI-TOF dendrogram for 26 isolates representing nine Burkholderia species (Fig 3). This demonstrated a broadly similar structure between the two, with distribution of the species between two major divisions. A notable difference was that MS distinguished between B. pseudomallei and B. mallei, while the recA tree did not.
MALDI-TOF MS is increasingly used for bacterial identification in diagnostic microbiology laboratories. This technology can reduce time of identification since bacteria are sampled directly from bacterial colonies and the test takes around 30 minutes to perform. The rapid microbiological diagnosis of melioidosis is essential because clinical features are non-specific, empiric drug regimens are sub-optimal, and infection is often fatal without appropriate treatment. This is compounded by the fact that healthcare providers in non-endemic countries may not readily recognize melioidosis. MALDI-TOF MS could also be used for environmental surveys looking at the distribution and presence of B. pseudomallei and related species.
Our findings confirm that MALDI-TOF MS can accurately identify B. pseudomallei regardless of geographic origin, and was able to reliably distinguish between this, other Burkholderia spp. and a range of other common pathogens, provided that the database is suitably modified. Since the top hit identification for each tested B. pseudomallei isolates could be any of five B. pseudomallei isolates in our reference database, we recommended laboratories that wish to identify B. pseudomallei using this method to extend the database by adding reference profiles of all five B. pseudomallei isolates. Diagnostic laboratories use a range of culture media, but we demonstrated that this has no effect on the performance of the test. We also showed that MALDI-TOF MS accurately identifies B. pseudomallei in blood cultures, which could reduce the time taken to diagnostic confirmation and appropriate antimicrobial treatment. Our results confirm a previous report in which MALDI-TOF was used to identify B. pseudomallei from blood cultures from two septicemic patients in Australia . The simulated blood culture experiment in which 10 CFU was used as the starting inoculum reflects the bacterial load in blood during human infection, which has been reported previously to be a median count of 1.1 CFU/ml . Our observation that identification of B. pseudomallei by MALDI-TOF was not accurate until after an incubation period of 24 hours implies that in clinical practice, this method will be effective on bottles that have flagged in an automated incubation system or after 24 hours or more of incubation.
The Clinprotools software used to support the interpretation of MALDI-TOF MS identifies species-specific peaks as the basis for species identification [30, 41, 49]. In agreement with previous studies [25, 30], we identified specific peaks at 4,410, 5,794, 6,551, 7,553 and 9,713 Da for all B. pseudomallei isolates tested. We also observed specific peaks for B. ubonensis (2,908 Da), B. vietnamiensis (3,932 Da) and B. thailandensis variants expressing Bp-like CPS (5,835 Da). The peak at 2,049 Da may be used to differentiate between B. pseudomallei and B. mallei because this was present in all B. pseudomallei isolates but not in any B. mallei isolates. We also noted several peaks which displayed significantly higher peak intensities in specific species, which may be useful for the discrimination of B. humptydooensis (2,049 Da), B. multivorans (3,686 Da), B. pseudomallei (5,797 Da), B. oklahomensis (6,589 and 7,901 Da) and B. vietnamiensis (7,859 Da).
Latex agglutination is a sensitive screening test for suspected B. pseudomallei, but positive latex agglutination results have been described previously for B. mallei, B. thailandensis with Bp-like CPS, S. aureus [11, 35, 50] and some strains of B. cepacia (unpublished data), potentially leading to confusion in diagnostic laboratories if used alone. This study shows that MALDI-TOF MS can be used to reliably distinguish between these organisms. Furthermore, both MSP and recA dendrograms confirmed that B. pseudomallei, B. mallei and B. thailandensis were arranged in the same phylogenetic group.
In conclusion, MALDI-TOF MS is an accurate and discriminatory tool for the identification of B. pseudomallei if sufficient MSPs are added in the Biotyper database. MALDI-TOF MS could be used to increase the rapid detection of cases of melioidosis in the clinical setting, and reduce time to appropriate antimicrobial therapy.
We gratefully acknowledge staff at Sunpasitthiprasong hospital, Nakhon Phanom hospital, Khon Kaen hospital, Udon Thani hospital, Budhasothorn Hospital, Mahidol-Oxford Tropical Medicine Research Unit (MORU), the Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University and the Microbiology Laboratory and wards of Mahosot Hospital. We thank Tsedev Ulziitogtokh and Erhan Akcay for providing bacterial isolates. We thank Suporn Paksanont, Sarunporn Tandhavanant, Premjit Amornchai, Rungnapa Punphang, Chakkaphan Runcharoen, Manivanh Vongsouvath, Viengmon Davong, Mayfong Mayxay and Paul Newton for their assistance.
- Conceptualization: VS NC.
- Data curation: VS NC.
- Formal analysis: VS NC.
- Funding acquisition: NC.
- Investigation: VS AP PE NC.
- Methodology: VS NC.
- Project administration: NC.
- Resources: PE VW MGE PT BJC RP DD DL NC.
- Software: VS.
- Supervision: NC SJP.
- Validation: VS.
- Visualization: SJP NC.
- Writing – original draft: NC.
- Writing – review & editing: VS AP PE VW MGE PT BJC DD DL SJP NC.
- 1. Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution of and burden of melioidosis. Nat Microbiol. 2016;1(1). pmid:26877885
- 2. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One. 2013;8(1):e54714. pmid:23349954
- 3. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367(11):1035–44. pmid:22970946
- 4. Saidani N, Griffiths K, Million M, Gautret P, Dubourg G, Parola P, et al. Melioidosis as a travel-associated infection: Case report and review of the literature. Travel Med Infect Dis. 2015;13(5):367–81. pmid:26385170
- 5. Jang HR, Lee CW, Ok SJ, Kim MJ, Bae MJ, Song S, et al. Melioidosis presenting as a mycotic aneurysm in a Korean patient, diagnosed by 16S rRNA sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Int J Infect Dis. 2015;38:62–4. pmid:26216763
- 6. Thaipadungpanit J, Chierakul W, Pattanaporkrattana W, Phoodaeng A, Wongsuvan G, Huntrakun V, et al. Burkholderia pseudomallei in water supplies, southern Thailand. Emerg Infect Dis. 2014;20(11):1947–9. pmid:25340393
- 7. Chantratita N, Wuthiekanun V, Limmathurotsakul D, Vesaratchavest M, Thanwisai A, Amornchai P, et al. Genetic diversity and microevolution of Burkholderia pseudomallei in the environment. PLoS Negl Trop Dis. 2008;2(2):e182. pmid:18299706
- 8. Wuthiekanun V, Limmathurotsakul D, Chantratita N, Feil EJ, Day NP, Peacock SJ. Burkholderia pseudomallei is genetically diverse in agricultural land in Northeast Thailand. PLoS Negl Trop Dis. 2009;3(8):e496. pmid:19652701
- 9. Glass MB, Gee JE, Steigerwalt AG, Cavuoti D, Barton T, Hardy RD, et al. Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol. 2006;44(12):4601–4. pmid:17050819
- 10. Chantratita N, Tandhavanant S, Wongsuvan G, Wuthiekanun V, Teerawattanasook N, Day NP, et al. Rapid detection of Burkholderia pseudomallei in blood cultures using a monoclonal antibody-based immunofluorescent assay. Am J Trop Med Hyg. 2013;89(5):971–2. pmid:24019434
- 11. Anuntagool N, Naigowit P, Petkanchanapong V, Aramsri P, Panichakul T, Sirisinha S. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol. 2000;49(12):1075–8. pmid:11129718
- 12. Houghton RL, Reed DE, Hubbard MA, Dillon MJ, Chen H, Currie BJ, et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis. 2014;8(3):e2727. pmid:24651568
- 13. Sim BM, Chantratita N, Ooi WF, Nandi T, Tewhey R, Wuthiekanun V, et al. Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol. 2010;11(8):R89. pmid:20799932
- 14. Chantratita N, Wuthiekanun V, Limmathurotsakul D, Thanwisai A, Chantratita W, Day NP, et al. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg. 2007;77(5):814–7. pmid:17984332
- 15. Chantratita N, Meumann E, Thanwisai A, Limmathurotsakul D, Wuthiekanun V, Wannapasni S, et al. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J Clin Microbiol. 2008;46(2):568–73. pmid:18039797
- 16. Smith MD, Angus BJ, Wuthiekanun V, White NJ. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect Immun. 1997;65(10):4319–21. pmid:9317042
- 17. Novak RT, Glass MB, Gee JE, Gal D, Mayo MJ, Currie BJ, et al. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol. 2006;44(1):85–90. pmid:16390953
- 18. Meumann EM, Novak RT, Gal D, Kaestli ME, Mayo M, Hanson JP, et al. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol. 2006;44(8):3028–30. pmid:16891534
- 19. Gee JE, Sacchi CT, Glass MB, De BK, Weyant RS, Levett PN, et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol. 2003;41(10):4647–54. pmid:14532197
- 20. Ginther JL, Mayo M, Warrington SD, Kaestli M, Mullins T, Wagner DM, et al. Identification of Burkholderia pseudomallei Near-Neighbor Species in the Northern Territory of Australia. PLoS Negl Trop Dis. 2015;9(6):e0003892. pmid:26121041
- 21. Koh TH, Yong Ng LS, Foon Ho JL, Sng LH, Wang GC, Tzer Pin Lin RV. Automated identification systems and Burkholderia pseudomallei. J Clin Microbiol. 2003;41(4):1809. pmid:12682195
- 22. Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol. 2002;40(12):4625–7. pmid:12454163
- 23. Lowe P, Haswell H, Lewis K. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN Card for identification of Burkholderia pseudomallei. J Clin Microbiol. 2006;44(3):854–6. pmid:16517866
- 24. Zong Z, Wang X, Deng Y, Zhou T. Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the VITEK 2 system. J Med Microbiol. 2012;61(Pt 10):1483–4. pmid:22820689
- 25. Karger A, Stock R, Ziller M, Elschner MC, Bettin B, Melzer F, et al. Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing. BMC Microbiol. 2012;12:229. pmid:23046611
- 26. Elschner MC, Hnizdo J, Stamm I, El-Adawy H, Mertens K, Melzer F. Isolation of the highly pathogenic and zoonotic agent Burkholderia pseudomallei from a pet green Iguana in Prague, Czech Republic. BMC Vet Res. 2014;10:283. pmid:25430942
- 27. Walewski V, Mechai F, Billard-Pomares T, Juguet W, Jaureguy F, Picard B, et al. MALDI-TOF MS contribution to diagnosis of melioidosis in a nonendemic country in three French travellers. New Microbes New Infect. 2016;12:31–4. pmid:27222715
- 28. Dingle TC, Butler-Wu SM, Abbott AN. Accidental exposure to Burkholderia pseudomallei in the laboratory in the era of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2014;52(9):3490–1. pmid:24920780
- 29. Inglis TJ, Healy PE, Fremlin LJ, Golledge CL. Use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis for rapid confirmation of Burkholderia pseudomallei in septicemic melioidosis. Am J Trop Med Hyg. 2012;86(6):1039–42. pmid:22665614
- 30. Niyompanich S, Srisanga K, Jaresitthikunchai J, Roytrakul S, Tungpradabkul S. Utilization of Whole-Cell MALDI-TOF Mass Spectrometry to Differentiate Burkholderia pseudomallei Wild-Type and Constructed Mutants. PLoS One. 2015;10(12):e0144128. pmid:26656930
- 31. Niyompanich S, Jaresitthikunchai J, Srisanga K, Roytrakul S, Tungpradabkul S. Source-identifying biomarker ions between environmental and clinical Burkholderia pseudomallei using whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). PLoS One. 2014;9(6):e99160. pmid:24914956
- 32. Cox CR, Saichek NR, Schweizer HP, Voorhees KJ. Rapid Burkholderia pseudomallei identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS. Bacteriophage. 2014;4:e29011. pmid:25050191
- 33. Lasch P, Wahab T, Weil S, Palyi B, Tomaso H, Zange S, et al. Identification of Highly Pathogenic Microorganisms by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry: Results of an Interlaboratory Ring Trial. J Clin Microbiol. 2015;53(8):2632–40. pmid:26063856
- 34. Wang H, Chen YL, Teng SH, Xu ZP, Xu YC, Hsueh PR. Evaluation of the Bruker Biotyper Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry System for Identification of Clinical and Environmental Isolates of Burkholderia pseudomallei. Front Microbiol. 2016;7:415. pmid:27092108
- 35. Duval BD, Elrod MG, Gee JE, Chantratita N, Tandhavanant S, Limmathurotsakul D, et al. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei. Am J Trop Med Hyg. 2014;90(6):1043–6. pmid:24710616
- 36. Chantratita N, Vesaratchavest M, Wuthiekanun V, Tiyawisutsri R, Ulziitogtokh T, Akcay E, et al. Pulsed-field gel electrophoresis as a discriminatory typing technique for the biothreat agent Burkholderia mallei. Am J Trop Med Hyg. 2006;74(3):345–7. pmid:16525089
- 37. Vesaratchavest M, Tumapa S, Day NP, Wuthiekanun V, Chierakul W, Holden MT, et al. Nonrandom distribution of Burkholderia pseudomallei clones in relation to geographical location and virulence. J Clin Microbiol. 2006;44(7):2553–7. pmid:16825379
- 38. Ferreira L, Sanchez-Juanes F, Munoz-Bellido JL, Gonzalez-Buitrago JM. Rapid method for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: intact cell vs. extraction method. Clin Microbiol Infect. 2011;17(7):1007–12. pmid:20718803
- 39. Drevinek M, Dresler J, Klimentova J, Pisa L, Hubalek M. Evaluation of sample preparation methods for MALDI-TOF MS identification of highly dangerous bacteria. Lett Appl Microbiol. 2012;55(1):40–6. pmid:22512320
- 40. Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I. Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect. 2012;18(11):1097–103. pmid:22085042
- 41. Calderaro A, Gorrini C, Piccolo G, Montecchini S, Buttrini M, Rossi S, et al. Identification of Borrelia species after creation of an in-house MALDI-TOF MS database. PLoS One. 2014;9(2):e88895. pmid:24533160
- 42. Calderaro A, Arcangeletti MC, Rodighiero I, Buttrini M, Montecchini S, Vasile Simone R, et al. Identification of different respiratory viruses, after a cell culture step, by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). Sci Rep. 2016;6:36082. pmid:27786297
- 43. Gekenidis MT, Studer P, Wuthrich S, Brunisholz R, Drissner D. Beyond the matrix-assisted laser desorption ionization (MALDI) biotyping workflow: in search of microorganism-specific tryptic peptides enabling discrimination of subspecies. Appl Environ Microbiol. 2014;80(14):4234–41. pmid:24795381
- 44. Prod'hom G, Bizzini A, Durussel C, Bille J, Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol. 2010;48(4):1481–3. pmid:20164269
- 45. Boyd MA, Tennant SM, Melendez JH, Toema D, Galen JE, Geddes CD, et al. Adaptation of red blood cell lysis represents a fundamental breakthrough that improves the sensitivity of Salmonella detection in blood. J Appl Microbiol. 2015;118(5):1199–209. pmid:25630831
- 46. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–9. pmid:21546353
- 47. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10(3):512–26. pmid:8336541
- 48. Wuthiekanun V, Limmathurotsakul D, Wongsuvan G, Chierakul W, Teerawattanasook N, Teparrukkul P, et al. Quantitation of B. pseudomallei in clinical samples. Am J Trop Med Hyg. 2007;77(5):812–3. pmid:17984331
- 49. Rettinger A, Krupka I, Grunwald K, Dyachenko V, Fingerle V, Konrad R, et al. Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST). BMC Microbiol. 2012;12:185. pmid:22925589
- 50. Amornchai P, Chierakul W, Wuthiekanun V, Mahakhunkijcharoen Y, Phetsouvanh R, Currie BJ, et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol. 2007;45(11):3774–6. pmid:17804660